Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2014
03/26/2014CN103664899A Heteroaryl-substituted dihydropyrimidine compounds and application thereof in medicines
03/26/2014CN103664898A Organometallic compound and organic light-emitting device including the same
03/26/2014CN103664897A Dihydropyrimidine compounds and application thereof in medicines
03/26/2014CN103664797A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664787A Alkyne heteraromatic ring compound and application thereof
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN102838589B Method for preparing N substituted pyrrolidine derivative through acylation of methyl sulfone chloride
03/26/2014CN102675293B Indole diketopiperazines derivatives, preparation method and application thereof
03/26/2014CN102250068B Preparation method for 1-methyl-4-(2-methyltetrazole-5-group)-5-sulfonylchloropyrazole
03/26/2014CN102202737B Disubstituted 2,3-phthalazine hedgehog pathway antagonists
03/26/2014CN102056905B Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
03/26/2014CN101426766B Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
03/25/2014US8680301 Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same
03/25/2014US8680274 Bent allenes, and their metal complexes
03/25/2014US8680270 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
03/25/2014US8680125 Fullerene therapies for inflammation
03/25/2014US8680119 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
03/25/2014US8680103 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
03/25/2014US8680102 Pyrrole derivatives, their preparation and their therapeutic application
03/25/2014US8680101 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use
03/25/2014US8680092 Nitrogenous heterocyclic compound and medicinal use thereof
03/25/2014US8680091 6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
03/25/2014US8679773 Kits pertaining to analyte determination
03/25/2014CA2699989C N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor
03/25/2014CA2617099C Macrocyclic inhibitors of hepatitis c virus
03/25/2014CA2594418C N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
03/20/2014WO2014042405A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/20/2014WO2014042321A1 Organic light-emitting compound and organic electroluminescent device using same
03/20/2014WO2014041106A1 Triazole carboxamide derivatives
03/20/2014WO2014041007A1 Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease
03/20/2014WO2014040969A1 2-oxo-2,3-dihydro-indoles for the treatment of cns disorders
03/20/2014WO2014040965A1 Inhibitors of bruton's tyrosine kinase
03/20/2014WO2014040555A1 Nitrogen-containing heteroaromatic ring derivative as tyrosine kinase inhibitor
03/20/2014WO2014021591A3 Novel compound, method for preparing same and pharmaceutical composition comprising same
03/20/2014WO2014009833A3 Complement pathway modulators and uses thereof
03/20/2014WO2014002058A3 Complement pathway modulators and uses thereof
03/20/2014WO2014002051A3 Complement pathway modulators and uses thereof
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080831 Compounds useful for treating cancer
03/20/2014US20140080829 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/20/2014US20140080828 Imidazolyl amide compounds and uses related thereto
03/20/2014US20140080826 Modulators of atp-binding cassette transporters
03/20/2014US20140080807 Substituted indazole derivatives active as kinase inhibitors
03/20/2014US20140080798 Vegfr3 inhibitors
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080780 identification of compounds that disperse tdp-43 inclusions
03/20/2014US20140080770 Arylalkylamine compound and process for preparing the same
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/20/2014US20140077175 Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/19/2014EP2707365A1 Hepatitis c virus inhibitors
03/19/2014EP2707361A1 Fused heterocyclic compounds as sodium channel modulators
03/19/2014EP2707359A1 Substituted indazole derivatives active as kinase inhibitors
03/19/2014EP2707358A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/19/2014CN103649078A Substituted phenyl compounds
03/19/2014CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649056A Fused heterocyclic compounds as sodium channel modulators
03/19/2014CN103649048A Indoleamine derivatives for the treatment of central nervous system diseases
03/19/2014CN103641835A AZapyrenes For Electronic Applications
03/19/2014CN103641819A Antipyrine derivative probe material for naked eye detections and identifications of Cr3+ and Cu2+ as well as preparation method thereof
03/19/2014CN103641818A Novel crystal form of tandospirone citrate, preparation method and applications
03/19/2014CN103641817A Novel crystal form of tandospirone citrate, preparation method and applications
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103059003B Benzimidazole-1,2,3-triazole compound having antifungal activity, and its preparation method
03/19/2014CN103052632B Dihydropyrazole Compounds
03/19/2014CN102686591B Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
03/19/2014CN102333771B Indole derivatives as crth2 receptor antagonists
03/19/2014CN102131788B Compounds and compositions as protein kinase inhibitors
03/19/2014CN102131777B Piperidyl acrylamide antogonists of CCR2
03/19/2014CN101952258B Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
03/18/2014US8674138 Binaphthalene derivatives, preparation method thereof and organic electronic device using the same
03/18/2014US8674113 Compounds
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8674100 Inhibitors of C-FMS kinase
03/18/2014US8674093 Process for the preparation of an orexin receptor antagonist
03/18/2014US8674091 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent
03/18/2014US8674089 Michael addition reaction product and active energy ray-curable composition
03/18/2014US8673961 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
03/18/2014US8673954 Benzimidazole derivatives
03/18/2014US8673905 Imidazo pyrazines
03/18/2014US8673891 Aminopyrazine derivative and medicine
03/18/2014CA2749174C Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
03/18/2014CA2743562C Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
03/18/2014CA2647677C Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/18/2014CA2647373C Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
03/18/2014CA2637590C Treatment of inflammatory disorders with triazole compounds
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039412A1 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
03/13/2014WO2014039411A1 Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
03/13/2014WO2014038867A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/13/2014WO2014038677A1 Novel aromatic heterocyclic derivative, organic electroluminescent element material, organic electroluminescent element material solution, and organic electroluminescent element
03/13/2014WO2014037480A1 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
03/13/2014WO2014037391A1 Moxonidine synthesis with the aid of organic bases
03/13/2014WO2014036686A1 Olmesartan medoxomil preparation method
03/13/2014US20140073783 Neprilysin inhibitors
03/13/2014US20140073782 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
03/13/2014US20140073656 SERMS for the Treatment of Estrogen Receptor-Mediated Disorders
03/13/2014US20140073642 Quinazoline derivatives for the treatment of viral infections and further diseases
03/13/2014US20140073639 Inhibition of antimicrobial targets with reduced potential for resistance
03/13/2014US20140073624 Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 626